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The prognostic significance of the type of first acute myo-
cardial infarction (Q wave versus non-Q wave) and Q wave
location (anterior versus inferoposterior) was determined
from a multicenter data base involving 777 placebo-treated
patients who were participants in the Multicenter Diltiazem
Post-Infarction Trial. There were 224 patients (29%) with a
non·Q wave infarction, 326 (42%) with an inferoposterior
Q wave infarction and 227 (29%) with an anterior Q wave
infarction.
Mean left ventricular ejection fraction was significantly
(p < 0.001) lower in patients with an anterior Q wave
infarction than in the other two groups (anterior Q wave
0.39; inferior Q wave 0.52; non-Q wave 0.53). Neverthe-
less, the total cardiac mortality rate during the follow-up
Several studies 0-8) have analyzed the incidence, clinical
characteristics and prognostic significance of infarct type (Q
wave versus non-Q wave) and Q wave location (anterior
versus inferior) in large heterogeneous groups of postinfarc-
tion patients, but only a few studies (9-16) have focused on
patients with a first myocardial infarction. Patients with a
first myocardial infarction are more homogeneous in their
risk profile and can be categorized much more accurately
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period (average 25 months per patient) was only marginally
higher (p =0.42) in the anterior Q wave group (8.4%) than
in the other two groups (inferoposterior Q wave 7.1 %;
non·Q wave 6.3%). The total first recurrent cardiac event
was somewhat higher (p =0.08) in the anterior Q wave
group (18.1 %) than in the other two groups (inferoposte·
rior Q wave 11.7%; non-Q wave 15.6%).
Survivorship analyses extending over 3 years revealed
that electrocardiographic classification of the type of first
infarction and Q wave location did not make significant
independent contributions to the risk of postinfarction
cardiac death or first recurrent cardiac event, either before
or after adjustment for baseline clinical variables.
, (J Am Coil CardioI1990;15:1201-7)
into different electrocardiographic (ECG) subsets than pa-
tients can with one or more prior infarctions. Furthermore,
non-Q wave infarction is less frequent in patients with a first
infarction than in patients with multiple recurrent infarctions
(3,7,8,15,17), and the prognostic significance of non-Q wave
infarction may be different in these two subsets. There is
general agreement that the myocardial damage observed
with a non-Q wave or an inferoposterior Q wave infarction is
considerably less extensive than that observed with an
anterior Q wave infarction. The purpose of this study was to
determine the independent prognostic significance of infarct
type (Q wave versus non-Q wave) and Q wave location
among patients with a first infarction after adjustment for
pertinent baseline clinical variables, especially those related
to postinfarction left ventricular function.
Methods
Study patients. The original cohort for the study included
the 1,234 placebo-treated patients in the Multicenter Dil-
tiazem Post-Infarction Trial, aged 25 to 75 years, who had a
0735-1097/90/$3.50
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documented acute myocardial infarction between February
1983 and June 1986. A detailed description of the design,
patients, data acquisition, data management and follow-up of
the Multicenter Diltiazem Post-Infarction Trial has been
previously reported (18). The diagnosis of acute myocardial
infarction required serum enzyme confirmation in patients
with symptoms or ECG changes, or both, suggestive of
acute myocardial infarction. Patients had regular follow-up
evaluations until a common termination date of June 30,
1987. Follow-up duration ranged from 12 to 52 months
(average 25 months per patient).
Data acquisition. The clinical variables collected for each
patient included demographic data, prior cardiac history,
course while in the coronary care unit, an initial qualifying
ECG, an additional predischarge follow-up ECG, predis-
charge radionuclide ejection fraction measurement and 24 h
Holter ECG monitoring. Routine clinical variables were
missing in <0.5% of the patients, follow-up ECGs were
missing in 11%, radionuclide ejection fraction measurement
was not performed in 12% and Holter monitoring was not
performed in 13%.
Definitions. Patients with a first infarction were identified
after patients with the following criteria were excluded:
1) clinical history of a previous (preenrollment) myocardial
infarction; 2) left or right bundle branch block pattern or
pacemaker rhythm on the initial qualifying ECG; or 3)
definite or probable evidence for a previous myocardial
infarction on the qualifying ECG according to the Manhattan
code (19). Patients with a first infarction were then catego-
rized by infarct type (Q wave versus non-Q wave) and Q
wave location according to the Manhattan code (19). Non-Q
wave infarction (n = 224) was defined by the absence of
diagnostic (;;::0.04 s) Q waves or changes of a true posterior
infarction (an RlS ratio ;;:: 1 in lead VJ)' Anterior Q wave
location was defined as diagnostic Q waves in leads VI to V4'
with or without Q waves in leads I, aVL, V5 or V6 (n = 227).
Inferoposterior Q wave location (n = 326) was defined as
diagnostic Q waves in diaphragmatic leads III and aVF (n =
309) or an RlS ratio ;;:: 1 in lead VI in'dicative of a true
posterior infarction (n = 17).
Variables. The following variables were preselected and
dichotomized as the principal, clinically meaningful covari-
ates for the analyses: age (;;::60 years), male gender, New
York Heart Association functional class (grade II to IV)
before the index infarction, beta-adrenergic blocker therapy
at randomization, any grade of pulmonary congestion on
chest X-ray study, blood urea nitrogen (>30 mg/dl), radio-
nuclide left ventricular ejection fraction «0.40) and frequent
(;;::101h) ventricular premature complexes on 24 h Holter
recording.
Therapy and end points. Concurrent therapy was man-
aged by the patient's personal physician. Two end points
were used in the analyses. The primary end point was
cardiac mortality; the secondary end point was a first recur-
rent cardiac event (nonfatal reinfarction or cardiac death,
whichever occurred first).
Statistical analysis. Baseline characteristics and outcome
event rates in subsets of patients were compared by using a
chi-square test. A two-sided p value <0.05 was considered
statistically significant. Cumulative cardiac mortality rates
over time in different subsets were described by Kaplan-
Meier curves (20), and differences between curves were
assessed by the log-rank test (21). To determine the inde-
pendent risk of infarct type and Q wave location for subse-
quent cardiac death, we used the Cox proportional hazards
survival model (22). In these analyses, we first selected
independent predictors of outcome among eight prespecified
baseline clinical variables (not including infarct type or
location) to create a baseline model. This was done sepa-
rately for the total study group and for patients with Q wave
infarction. The final models included variables that were
selected for either group. Infarct type and Q wave location
were then added to their appropriate model to determine
their independent contribution after adjustment for pertinent
baseline variables. The independent risk for subsequent
cardiac death carried by each predictor variable is reported
in terms of the hazard ratio-the ratio of the risk of experi-
encing an event per unit of time for patients with a certain
predictor variable to the risk for patients without the same
predictor variable, adjusting for all other variables in the
model. To determine whether the inclusion of beta-blocker
therapy (a nonstudy intervention variable) in the analysis
may have resulted in major changes in the final models, all
analyses were repeated omitting beta-blocker therapy as a
predictor variable. The reported analyses utilized the Multi-
center Diltiazem Post-Infarction Trial analytic data base
released April 16, 1988.
Results
From an original cohort of 1,234 patients, 416 (34%) were
excluded from the analysis because of their medical history
(n = 259) or ECG evidence (n = 157) of prior (preenrollment)
infarction; an additional 41 patients (3.3%) were excluded
because of a missing ECG (n = 1), an ECG pattern of left
(n = 9) or right (n = 29) bundle branch block or pacemaker
rhythm (n = 2). The remaining 777 patients (63%) were
categorized as patients with a first myocardial infarction; 224
(29%) had a non-Q wave infarction, 227 (29%) had an
anterior Q wave infarction and 326 (42%) had an inferopos-
terior Q wave infarction, as defined under Methods.
Infarct type (Q wave versus non·Q wave) (Table 1). Pa-
tients with a non-Q wave infarction were more likely to be
women who had been treated with a beta-blocker at random-
ization and they were less likely to have a reduced «0.40)
postinfarction radionuclide ejection fraction than were pa-
tients with Qwave infarction. Outcome event rates were not
significantly different in the two subsets at 1 year or during
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*Mean left ventricular ejection fraction (LVEF): 0.46 ± 0.13 versus
0.53 ± 0.12 for Qwave and non-Q wave, respectively (p < 0.001); tp < 0.05;
tp < 0.001. BUN = blood urea nitrogen; NYHA class = New York Heart
Association functional class; VPCs = ventricular premature complexes.
Table 1. Clinical Characteristics and Outcome Events of Patients
With First Q Wave and First Non-Q Wave Myocardial Infarction
QWave Non-Q Wave
(n = 553) (n = 224)
(%) (%)
Characteristic ......
Age (;;:,60 yr) 48 49 ~~
Male gender 80 74t ~NYHA class (II-IV) 10 13 ~Beta-blocker therapy 47 61*
Pulmonary congestion 18 16 ~
BUN (>30 mg/dl) 9 9 ::i~LVEF «0.40)* 30 1U ex:
VPCs (;;:'IO/h) 14 14 Q
I Year outcome event rate ~
Cardiac death 5.2 4.0 (,)SFirst recurrent cardiac event 9.9 11.2 0
Total follow-up outcome event rate ex:
Cardiac death 7.6 6.3 (3
First recurrent cardiac event 14.3 15.6
the total follow-up period, although the cardiac death rate
was somewhat lower at both time intervals among patients
with a non-Q wave infarction. The cumulative cardiac mor-
tality rates over time were similar for the two infarct types
(Fig. 1).
Anterior Qwave versus inferoposterior Qwave infarction
(Table 2). Patients with anterior Q wave infarction were
more likely to be men with pulmonary congestion and to
have reduced «0.40) left ventricular ejection fraction than
were patients with inferoposterior Q wave infarction. Out-
come event rates at I year exhibited a nonsignificant trend
toward more events among patients with anterior Q wave
infarction than among those with inferoposterior Q wave
infarction. Total follow-up cardiac mortality had the same
trend, but first recurrent cardiac event rates at total follow-
up evaluation were higher (p < 0.05) among patients with
anterior Q wave than among those with inferoposterior Q
wave infarction. The cumulative cardiac mortality rates over
time were similar for the two infarct locations (Fig. 2).
Cox regression analyses. To determine the independent
contribution of infarction type and Q wave location to the
risk of subsequent cardiac death, we used the Cox survivor-
ship technique. From the eight baseline variables listed in
Table I, four variables were selected in a stepwise fashion to
construct the best Cox survivorship model. Infarct type
(among the total study group) and Q wave location (among
patients with Q wave infarction) were then added, one at a
time, to that baseline model to determine whether their
addition to the model significantly changed its performance.
The results of these two models are presented in Table 3
Figure 1. Cumulative cardiac mortality rate by first infarction type
(Q wave versus non-Q wave).
(model 1 for infarct type and model 2 for Q wave location).
Although the hazard ratio, after adjustment for baseline
variables, was greater than unity for Q wave infarction (1.34)
Table 2. Clinical Characteristics and Outcome Events in Patients
With First Anterior and Inferoposterior QWave Infarction
Anterior Inferoposterior
QWave QWave
(n = 227) (n = 326)
(%) (%)
Characteristic
Age (;;:,60 yr) 48 48
Male gender 85 77t
NYHA class (II-IV) 11 10
Beta-blocker therapy 46 48
Pulmonary congestion 26 13t
BUN (>30 mg/dl) 8 10
LVEF «0.40)* 56 12t
VPCs (;;:'IO/h) 14 14
I Year outcome event rate
Cardiac death 6.6 4.3
First recurrent cardiac event 12.3 8.3
Total follow-up outcome event rate
Cardiac death 8.4 7.1
First recurrent cardiac event 18.1 l1.7t
*Mean left ventricular ejection fraction: 0.39 ± 0.12 versus 0.52 ± 0.11 for
anterior Q wave and inferoposterior Q wave, respectively (p < 0.001);
tp < 0.05; tp < 0.001. Abbreviations as in Table 1.
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Table 3. Baseline Clinical Predictors of Cardiac Mortality
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Discussion
The principal finding of this study is that ECG classifica-
tion of first myocardial infarction by infarct type (Q wave
versus non-Q wave) or Q wave location (anterior versus
inferoposterior) does not make a significant contribution to
the risk of postinfarction cardiac death, either before or after
adjustment for pertinent baseline clinical variables.
Previous studies. Numerous previous studies (23-30)
have highlighted the major prognostic role of postinfarction
mechanical dysfunction, which is by far the most important
risk variable in most postinfarction patients. Anteriorly
located Q wave infarction has been associated with more
extensive myocardial damage than that observed after non-Q
wave and inferior Q wave infarction (2,3,5-14,16). Several
studies (6,7,13) have shown that the occurrence ofQ waves
in the anterior location is associated with significant postin-
farction mechanical dysfunction and increased cardiac mor-
tality. Thus, trying to determine the independent prognostic
role of these ECG covariates after adjustment for clinical
variables representing postinfarction mechanical dysfunc-
tion and other related characteristics seems relevant, espe-
cially in view of the existing controversy in this regard and
the common use of these covariates in the clinical setting.
Many previous reports (1-8) that have addressed this issue
used heterogeneous postinfarction groups of patients that
included patients with one or more prior infarctions (typical-
ly, 20% to 35% of the study patients had prior infarction).
Patients with a prior myocardial infarction are older and
have previous myocardial damage and more advanced cor-
onary artery disease (15). Thus, any clinical variable, espe-
cially one representing mechanical dysfunction, might carry
a different risk among patients with multiple infarctions than
among those after a first myocardial infarction. In addition,
the accuracy of ECG criteria for infarct type and location is
greatly compromised when applied to patients with prior
infarction. Accordingly, in our analysis, we included only
patients with a single (first) myocardial infarction. The
clinical characteristics of patients classified according to
infarct type and location in our study were similar to those of
corresponding patients in most previous studies (9-16) that
have focused on patients with a first infarction. However,
our results differ from those of earlier reported studies in that
neither the type nor the location of a first infarct location
made an independent contribution to cardiac mortality,
either before or after adjustment for pertinent baseline
clinical covariates.
Infarct type (Q wave versus non.Q wave). Much of the
controversy regarding the independent prognostic signifi-
cance of infarct type can be explained by the heterogeneity
similar. All analyses were repeated after omitting beta-
blocker therapy as a predictor variable, and the results were
also similar.
Hazard Ratio
(95% CI)
(n =482)
0.76 (0.37, 1.56)
2.15 (0.96, 4.84)
2.00 (0.84, 4.77)
2.07 (0.84, 5.13)
1.74 (0.74, 4.06)
Model 2: Q wave
Infarct Location
Hazard Ratio
(95% CI)
(n = 667)
2.50 (1.29, 4.87)
2.33 (1.12, 4.83)
2.17 (0.99, 4.76)
1.57 (0.76, 3.23)
1.34 (0.65, 2.76)
p = 0.64
Model I: Infarct Type
!
i·················
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Figure 2. Cumulative cardiac mortality rate by first infarction loca-
tion in patients with Q wave infarction (anterior versus inferopos-
terior).
VPCs «dOlh)
No beta-blocker therapy
NYHA class (II-IV)
Pulmonary congestion
Q wavet
Anterior Q wave+
and less than unity for anterior Q wave infarction (0.76), the
confidence intervals of the hazard ratios for these ECG
variables overlapped unity, indicating nonsignificant effects.
Thus, neither infarct type (Q wave versus non-Q wave) nor
Q wave location (anterior versus inferoposterior) made an
independent contribution to the risk of subsequent cardiac
death. Results of similar analyses carried out using first
recurrent cardiac event as the outcome end point were
'No beta-blocker versus beta-blocker use at entry. tQ wave versus non-Q
wave infarction. +Anterior Q wave versus inferoposterior Q wave infarction.
Modell relates to infarct type (Q wave versus non-Q wave), whereas model
2 relates to Q wave infarct location (anterior Q versus inferoposterior Q
wave). See text for details. CI = confidence interval; other abbreviations as in
Table I.
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that exists among these electrocardiographically defined
subsets. Several previous pathologic studies (17,31-36)
pointed out the suboptimal correlation between non-Q wave
infarct type and several morphologic characteristics that
relate to the anatomic location and absolute extent of the
infarction. In addition, Freifeld et al. (17) reported a higher
incidence of histologic evidence for prior infarction among
patients with a fatal non-Q wave than among those with a
fatal Q wave infarction. Previous clinical studies confirm this
finding. The reported incidence of a non-Q wave infarction
among patients with a first infarction (6% to 31%) (9-11,13-
16) is lower than that reported among patients after multiple
infarctions (24% to 44%) (3,7,8,15,37). The occurrence of a
non-Q wave infarction as a first cardiac event differs prog-
nostically from its occurrence as a recurrent cardiac event,
as recently reported by Nicod et al. (37).
Even among patients with a first infarction, a substantial
prognostic heterogeneity of non-Q wave infarct type still
exits. Krone et al. (12) reported a 2 year mortality rate of
3.2% among patients with a first non-Q wave infarction, a
rate that was significantly lower than that observed among
patients with a first Q wave infarction. The mortality rate
among patients with a first non-Q wave infarction from the
third postinfarction year on, however, was dependent on
age; only those >60 years had an increased mortality rate
(12% per year), whereas younger patients continued to have
a very low mortality rate. A similar finding was reported by
Nicod et al. (37) using 70 years of age as the cut point and 1
year follow-up period. The relative proportion of infarct type
subsets in our study (29% non-Q wave) is similar to that
reported by others (9-16,37). Patients with a first non-Q
wave infarction were more likely to be women and had
evidence of less extensive myocardial damage than did
patients with a first Q wave infarction. Of special interest
was the nonconcordant distribution of reduced left ventric-
ular ejection fraction and pulmonary congestion among the
two infarct type subsets in our study. Mean left ventricular
ejection fraction was significantly higher among patients
with non-Q wave than among those with Q wave infarction
(p = 0.001), whereas pulmonary congestion was observed in
similarfrequencies among the two subsets (16% versus 18%,
respectively). This finding might suggest that pulmonary
congestion in the setting of a first non-Q wave infarction is
mainly related to reversible ischemia, whereas in the setting
of a Q wave infarction, the dominant mechanism is the acute
impact of irreversible myocardial damage. Several previous
studies (7,8,13) have emphasized the prognostic role of
postinfarction residual ischemia in patients with a non-Q
wave infarction. Our study design did not include residual
ischemia detection covariates so we cannot verify this asso-
ciation.
Q wave infarct location (anterior versus inferoposterior).
Conflicting results have been reported in several studies that
investigated the independent prognostic significance of Q
wave infarct location among patients with a first infarction.
Most studies (14-16) concluded that infarct location is an
independent predictor for subsequent cardiac mortality; one
study (9) did not find this to be the case. Our results are in
accord with the latter. This controversy might be partially
related to the use of different ECG criteria, but it most
probably relates to the characteristics of the patients studied
and the different analytic designs employed. Geltman et al.
(9) did not report any specific exclusion criteria. Hands et al.
(14) excluded patients with true posterior infarction, those
with no ECG changes and some patients with only T wave
changes. Stone et al. (16) excluded patients with combined
anterior and inferior infarction. We did not exclude any Q
wave infarct location subtype from the analysis. Further-
more, to minimize the error involved in the ECG categori-
zations, we applied infarct location criteria only to patients
with Q wave infarction.
Role of infarct size. Adjustment for infarct size was
accomplished in most previous studies by stratifying patients
according to myocardial enzyme release. Enzyme level
estimates of infarct size have been shown (38,39) to correlate
with the magnitude of the myocardial infarction, but these
techniques are limited in estimating the extent of left ven-
tricular damage mainly because of right ventricular enzyme
release in the setting of an inferoposterior infarction. Stone
et al. (16) stratified 471 patients after a first infarction by
enzymatically determined quartiles of infarct size index, and
differences in left ventricular ejection fraction were noted
between the two infarct location subsets within each quar-
tile. Patients with an anterior infarction had a significantly
lower left ventricular ejection fraction than did patients with
an inferior infarction. Although the original design of that
study (16) included direct measures of postinfarction left
ventricular function, these covariates were not used in the
adjustment procedure for infarct size in our study. Further-
more, the final multivariate analysis in that study included
infarct type, location and enzymatically determined size, but
baseline clinical left ventricular function variables were not
included. Hands et al. (14) followed up 789 patients for 1
year after their first myocardial infarction. Patients with an
anteriorly located infarct had a higher mortality rate than did
those with an inferior infarction (18.3% versus 10.5%, re-
spectively). Adjustment for infarct size was carried out by
stratifying patients according to peak creatine kinase levels.
A higher mortality rate was observed among patients with
anterior compared with inferior infarction even after adjust-
ment for enzymatic infarct size, but the difference between
the mortality rates in the two subsets was significant only in
two of four infarct size subgroups. The analysis performed in
that study did not include direct baseline estimators of left
ventricular function.
In the present study, first anterior Q wave location did not
make a significant contribution to the risk of subsequent
cardiac mortality. Our patients may have been less sick than
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were those investigated in the earlier reported studies. They
were from the placebo arm of the Multicenter Diltiazem
Post-Infarction Trial (18), and patients who refused to par-
ticipate in the trial may have contributed to a selection bias.
In addition, patients were not enrolled until 3 to 15 days after
the onset of the acute infarction; thus patients with a high
early mortality rate were excluded.
Other comments: possible limitations. Although our anal-
ysis was carried our retrospectively, it was based on pro-
spectively acquired data. Patients with prior infarction were
excluded from the analysis according to historical as well as
strict ECG criteria. Such criteria are never pure, yet they
probably improve the quality of the data in view of the 23%
incidence of unrecognized infarcts (half of which were silent)
among patients with a first infarction reported in the
Framingham Study (40). Although beta-blocker therapy was
a nonstudy intervention variable, it was included in the
analysis because of its imbalance in infarct type and location
subsets. All analyses were repeated after omitting beta-
blocker therapy, and the results were similar. Other non-
study interventions were uncommon and were balanced
among most subsets. Twenty-three percent of the patients
were treated with aspirin at randomization, and coronary
bypass surgery and coronary angioplasty were performed in
14.5% and 2%, respectively, of the patients during the entire
follow-up period. Although most independent predictor var-
iables in our final multivariate model were related to left
ventricular mechanical status, left ventricular ejection frac-
tion was not found to be an independent predictor after
adjustment for the other variables. This finding might be
related to the specific dichotomy we used for ejection
fraction (40%) or to the association of other selected cova-
riates (such as advanced New York Heart Association
functional class and pulmonary congestion) with ejection
fraction.
The failure to demonstrate a significantly increased mor-
tality rate in those with anterior Q wave myocardial infarc-
tion compared with those having an inferoposterior Q wave
infarction despite a significantly reduced ejection fraction in
the former group raises the question of a possible type II
error. With a larger sample size, a statistically significant
mortality differential between the two subsets might have
been detected, but its clinical significance as reflected by its
hazard ratio would be overshadowed by the more important
mechanical and electrical risk factors already identified
(Table 3). It is unlikely that a longer duration of follow-up
would have identified a significant mortality differential
among the investigated subsets because the unadjusted
survivorship functions (Fig. I and 2) approached each other
after the second postinfarction year.
We thank Shirley Eberly for statistical assistance, and Anita Oberer for her
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